Long term disease-free survival resulting from combined modality management of patients presenting with oligometastatic, non-small cell lung carcinoma (NSCLC).
暂无分享,去创建一个
R. Abrams | S. Shott | Atif J. Khan | P. Mehta | P. Bonomi | T. Zusag | L. Penfield Faber